TABLE 4.

Unadjusted and adjusted analyses of neutrophil count (×10⁹/L), leukocyte count (×10⁹/L), NLR with mortality at 90 days.

Parameters	Cell counts (109/L) in quartiles	Unadjusted analysis		Model 1†		Model 2‡
		OR (95% CI)	p value	OR (95% CI)	p value	OR (95% CI)	p value
Leukocyte	<8.40	Reference	0.003	Reference	0.032	Reference	0.054
	8.40–11.06	1.42(0.88–2.27)	0.150	1.32(0.74–2.34)	0.352	1.31(0.69–2.50)	0.410
	11.06–13.66	1.65(1.03–2.64)	0.039	1.20(0.67–2.16)	0.536	1.29(0.67–2.46)	0.444
	>13.66	2.42(1.51–3.88)	<0.001	2.30(1.28–4.13)	0.005	2.40(1.25–4.62)	0.009
Neutrophil	<6.60	Reference	0.001	Reference	0.006	Reference	0.008
	6.60–9.15	1.68(1.05–2.70)	0.032	1.32(0.74–2.37)	0.352	1.24(0.65–2.39)	0.512
	9.15–11.96	1.61(1.001–2.59)	0.050	1.08(0.60–1.95)	0.786	1.13(0.59–2.18)	0.709
	>11.96	2.64(1.64–4.25)	<0.001	2.55(1.41–4.60)	0.002	2.75(1.42–5.32)	0.003
NLR	<4.96	Reference	0.005	Reference	0.027	Reference	0.017
	4.96–7.93	1.56(0.97–2.50)	0.068	1.66(0.92–3.00)	0.093	1.73(0.88–3.40)	0.115
	7.93–12.63	1.99(1.24–3.19)	0.005	1.82(1.004–3.32)	0.049	1.96(0.99–3.89)	0.053
	>12.63	2.22(1.38–3.56)	0.001	2.50(1.38–4.55)	0.003	2.98(1.51–5.88)	0.002
Leukocyte, 109/L		1.08(1.03–1.13)	<0.001	1.08(1.02–1.14)	0.004	1.09(1.03–1.15)	0.005
Neutrophil, 109/L		1.08(1.04–1.13)	<0.001	1.09(1.03–1.15)	0.002	1.10(1.04–1.17)	0.002
NLR		1.02(1.00–1.04)	0.085	1.02(1.00–1.05)	0.046	1.02(0.996–1.05)	0.098

^†Model 1 adjusted for age, sex, hypertension, diabetes mellitus, baseline NIHSS score, baseline pc-ASPECTS, PC-CS score, stroke etiology, occlusion sites and pass.

^‡Model 2 excluded patients without successful recanalization and adjusted for confounding factors in model 1.

OR, odds ratio; NLR, neutrophil-to-lymphocyte ratio; mRS, modified Rankin Scale.